Critical reviews in oral biology & medicine: Destructive and protective roles of cytokines in periodontitis: A re-appraisal from host defense and tissue destruction viewpoints

Journal of Dental Research

Volumn 89, Issue 12, 2010, Pages 1349-1363

  Garlet, G P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

adaptive immunity; bone resorption; cytokines; infection; inflammation; innate immunity; periodontal disease; T helper

Indexed keywords

AUTACOID; CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; DISEASE COURSE; HELPER CELL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MICROBIOLOGY; PERIODONTITIS; REGULATORY T LYMPHOCYTE; REVIEW;

ADAPTIVE IMMUNITY; CYTOKINES; DISEASE PROGRESSION; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; PERIODONTITIS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650083063     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510376402     Document Type: Review

References (209)

1. Abiko Y., Nishimura M., Kaku T. (2003). Defensins in saliva and the salivary glands. Med Electron Microsc 36: 247-252.
2. Agnello D., Lankford CS, Bream J., Morinobu A., Gadina M., O'Shea JJ, et al. (2003). Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 23: 147-161.
3. Aoyagi T., Yamazaki K., Kabasawa-Katoh Y., Nakajima T., Yamashita N., Yoshie H., et al. (2000). Elevated CTLA-4 expression on CD4 T cells from periodontitis patients stimulated with Porphyromonas gingivalis outer membrane antigen. Clin Exp Immunol 119: 280-286.
4. Appay V., van Lier RA, Sallusto F., Roederer M. (2008). Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73: 975-983.
5. Ara T., Kurata K., Hirai K., Uchihashi T., Uematsu T., Imamura Y., et al. (2009). Human gingival fibroblasts are critical in sustaining inflammation in periodontal disease. J Periodontal Res 44: 21-27.
6. Ariel A., Serhan CN (2007). Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 28: 176-183.
7. Baker PJ, Dixon M., Evans RT, Dufour L., Johnson E., Roopenian DC (1999). CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 67: 2804-2809.
8. Baker PJ, Boutaugh NR, Tiffany M., Roopenian DC (2009). B cell IgD deletion prevents alveolar bone loss following murine oral infection. Interdiscip Perspect Infect Dis 2009: 864-359.
9. Bar-Shavit Z. (2008). Taking a toll on the bones: regulation of bone metabolism by innate immune regulators. Autoimmunity 41: 195-203.
10. Behl Y., Siqueira M., Ortiz J., Li J., Desta T., Faibish D., et al. (2008). Activation of the acquired immune response reduces coupled bone formation in response to a periodontal pathogen. J Immunol 181: 8711-8718.
11. Beklen A., Ainola M., Hukkanen M., Gurgan C., Sorsa T., Konttinen YT (2007). MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res 86: 347-351.
12. Beklen A., Sorsa T., Konttinen YT (2009). Toll-like receptors 2 and 5 in human gingival epithelial cells co-operate with T-cell cytokine interleukin-17. Oral Microbiol Immunol 24: 38-42.
13. Belkaid Y. (2007). Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 7: 875-888.
14. Belkaid Y., Tarbell K (2009). Regulatory T cells in the control of host-microorganism interactions. Annu Rev Immunol 27: 551-589.
15. Belkaid Y., Piccirillo CA, Mendez S., Shevach EM, Sacks DL (2002). CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
16. Bjarnsholt T., Kirketerp-Moller K., Jensen PO, Madsen KG, Phipps R., Krogfelt K., et al. (2008). Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 16: 2-10.
17. Bloemen V., Schoenmaker T., de Vries TJ, Everts V. (2010). Direct cell-cell contact between periodontal ligament fibroblasts and osteoclast precursors synergistically increases the expression of genes related to osteoclastogenesis. J Cell Physiol 222: 565-573.
18. Bluestone JA, Mackay CR, O'Shea JJ, Stockinger B. (2009). The functional plasticity of T cell subsets. Nat Rev Immunol 9: 811-816.
19. Bostanci N., Emingil G., Saygan B., Turkoglu O., Atilla G., Curtis MA, et al. (2009). Expression and regulation of the NALP3 inflammasome complex in periodontal diseases. Clin Exp Immunol 157: 415-422.
20. Burns E., Eliyahu T., Uematsu S., Akira S., Nussbaum G. (2010). TLR2-dependent inflammatory response to Porphyromonas gingivalis is MyD88 independent, whereas MyD88 is required to clear infection. J Immunol 184: 1455-1462.
21. Cardoso CR, Garlet GP, Moreira AP, Junior WM, Rossi MA, Silva JS (2008). Characterization of CD4+CD25+ natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. J Leukoc Biol 84: 311-318.
22. Cardoso CR, Garlett GP, Crippa GE, Rosa AL, Martins W. Jr, Rossi MA, Silva JS (2009). Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol 24: 1-6.
23. Chou WY, Lu CN, Lee TH, Wu CL, Hung KS, Concejero AM, et al. (2006). Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation. Acta Pharmacol Sin 27: 469-476.
24. Claudino M., Trombone AP, Cardoso CR, Ferreira SB Jr, Martins W. Jr, Assis GF, et al. (2008). The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. J Leukoc Biol 84: 1565-1573.
25. Claudino M., Garlet TP, Cardoso CR, de Assis GF, Taga R., Cunha FQ, et al. (2010). Down-regulation of expression of osteoblast and osteocyte markers in periodontal tissues associated with the spontaneous alveolar bone loss of interleukin-10 knockout mice. Eur J Oral Sci 118: 19-28.
26. Cochran DL (2008). Inflammation and bone loss in periodontal disease. J Periodontol 79 (8 Suppl). 1569S - 1576S.
27. Cornelis P. (2009). Shielding, a new pathogen defence mechanism against PMNs. Microbiology 155 (Pt 11). 3474-3475.
28. Costalonga M., Batas L., Reich BJ (2009). Effects of Toll-like receptor 4 on Porphyromonas gingivalis-induced bone loss in mice. J Periodontal Res 44: 537-542.
29. Costerton W., Veeh R., Shirtliff M., Pasmore M., Post C., Ehrlich G. (2003). The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112: 1466-1477.
30. Cronstein BN (2007). Interleukin-6-a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp Jt Dis 65 (Suppl 1). 11-15.
31. Cutler CW, Jotwani R. (2004). Antigen-presentation and the role of dendritic cells in periodontitis. Periodontol 2000 35: 135-157.
32. Dinarello CA (2000). Proinflammatory cytokines. Chest 118: 503-508.
33. Ding J., Ghali O., Lencel P., Broux O., Chauveau C., Devedjian JC, et al. (2009). TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci 84: 499-504.
34. Donati M., Liljenberg B., Zitzmann NU, Berglundh T. (2009). B-1a cells and plasma cells in periodontitis lesions. J Periodontal Res 44: 683-688.
35. Dong C. (2008). TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8: 337-348.
36. N. Dutzan, Gamonal J., Silva A., Sanz M., Vernal R. (2009 a). Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis. J Clin Periodontol 36: 396-403.
37. Dutzan N., Vernal R., Hernandez M., Dezerega A., Rivera O., Silva N., et al. (2009b). Levels of interferon-gamma and transcription factor T-bet in progressive periodontal lesions in patients with chronic periodontitis. J Periodontol 80: 290-296.
38. Eastcott JW, Yamashita K., Taubman MA, Harada Y., Smith DJ (1994). Adoptive transfer of cloned T helper cells ameliorates periodontal disease in nude rats. Oral Microbiol Immunol 9: 284-299.
39. Ferreira SB Jr, Trombone AP, Repeke CE, Cardoso CR, Martins W. Jr, Santos CF, et al. (2008). An interleukin-1beta (IL-1beta) single-nucleotide polymorphism at position 3954 and red complex periodontopathogens independently and additively modulate the levels of IL-1beta in diseased periodontal tissues. Infect Immun 76: 3725-3734.
40. Fine DH (2009). Of mice and men: animal models of human periodontal disease. J Clin Periodontol 36: 913-914.
41. Fine DH, Kaplan JB, Kachlany SC, Schreiner HC (2006). How we got attached to Actinobacillus actinomycetemcomitans: a model for infectious diseases. Periodontol 2000 42: 114-157.
42. Fonseca JE, Santos MJ, Canhao H., Choy E. (2009). Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 8: 538-542.
43. Fukui M., Hinode D., Yokoyama M., Tanabe S., Yoshioka M. (2006). Salivary immunoglobulin A directed to oral microbial GroEL in patients with periodontitis and their potential protective role. Oral Microbiol Immunol 21: 289-295.
44. Gaffen SL, Hajishengallis G. (2008). A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 87: 817-828.
45. Gao Y., Grassi F., Ryan MR, Terauchi M., Page K., Yang X., et al. (2007). IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 117: 122-132.
46. Garlet GP, Martins W. Jr, Ferreira BR, Milanezi CM, Silva JS (2003). Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 38: 210-217.
47. Garlet GP, Martins W. Jr, Fonseca BA, Ferreira BR, Silva JS (2004). Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 31: 671-679.
48. Garlet GP, Cardoso CR, Campanelli AP, Martins W. Jr, Silva JS (2006 a). Expression of suppressors of cytokine signaling in diseased periodontal tissues: a stop signal for disease progression ? J Periodontal Res 41: 580-584.
49. Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, et al. (2006 b). Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 21: 12-20.
50. Garlet GP, Cardoso CR, Campanelli AP, Ferreira BR, Avila-Campos MJ, Cunha FQ, et al. (2007). The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol 147: 128-138.
51. Garlet GP, Cardoso CR, Campanelli AP, Garlet TP, Avila-Campos MJ, Cunha FQ, et al. (2008). The essential role of IFN-gamma in the control of lethal Aggregatibacter actinomycetemcomitans infection in mice. Microbes Infect 10: 489-496.
52. Garlet GP, Cardoso CR, Mariano FS, Claudino M., Assis GF, Campanelli AP, et al. (2010). Regulatory T cells attenuate experimental periodontitis progression in mice. J Clin Periodontol 37: 591-600.
53. Gelani V., Fernandes AP, Gasparoto TH, Garlet TP, Cestari TM, Lima HR, et al. (2009). The role of Toll-like receptor 2 in the recognition of Aggregatibacter actinomycetemcomitans. J Periodontol 80: 2010-2019.
54. Gemmell E., Seymour GJ (2004). Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 35: 21-41.
55. Gemmell E., Carter CL, Grieco DA, Sugerman PB, Seymour GJ (2002 a). P. gingivalis-specific T-cell lines produce Th1 and Th2 cytokines. J Dent Res 81: 303-307.
56. Gemmell E., Yamazaki K., Seymour GJ (2002 b). Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med 13: 17-34.
57. Gemmell E., Yamazaki K., Seymour GJ (2007). The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol 2000 43: 14-40.
58. Giannobile WV (2008). Host-response therapeutics for periodontal diseases. J Periodontol 79 (8 Suppl). 1592S - 1600S.
59. Giannopoulou C., Kamma JJ, Mombelli A. (2003). Effect of inflammation, smoking and stress on gingival crevicular fluid cytokine level. J Clin Periodontol 30: 145-153.
60. Gibson FC 3rd, Savelli J., Van Dyke TE, Genco CA (2005). Gingipainspecific IgG in the sera of patients with periodontal disease is necessary for opsonophagocytosis of Porphyromonas gingivalis. J Periodontol 76: 1629-1636.
61. Gonçalves LD, Oliveira G., Hurtado PA, Feitosa A., Takiya CM, Granjeiro JM, et al. (2008). Expression of metalloproteinases and their tissue inhibitors in inflamed gingival biopsies. J Periodontal Res 43: 570-577.
62. Graves D. (2008). Cytokines that promote periodontal tissue destruction. J Periodontol 79 (8 Suppl). 1585S - 1591S.
63. Graves DT, Cochran D. (2003). The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 74: 391-401.
64. Graves DT, Fine D., Teng YT, Van Dyke TE, Hajishengallis G. (2008). The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol 35: 89-105.
65. Graves DT, Li J., Cochran DL (2010). Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res (in press).
66. Guentsch A., Puklo M., Preshaw PM, Glockmann E., Pfister W., Potempa J., et al. (2009). Neutrophils in chronic and aggressive periodontitis in interaction with Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. J Periodontal Res 44: 368-377.
67. Gustafsson A., Ito H., Asman B., Bergstrom K. (2006). Hyper-reactive mononuclear cells and neutrophils in chronic periodontitis. J Clin Periodontol 33: 126-129.
68. Gyurko R., Boustany G., Huang PL, Kantarci A., Van Dyke TE, Genco CA, et al. (2003). Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis. Infect Immun 71: 4917-4924.
69. Haffajee AD, Socransky SS (2005). Microbiology of periodontal diseases: introduction. Periodontol 2000 38: 9-12.
70. Hajishengallis G. (2009). Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? Microbes Infect 11: 637-645.
71. Hajishengallis G., Lambris JD (2010). Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol 31: 154-163.
72. Hajishengallis G., Wang M., Liang S., Triantafilou M., Triantafilou K. (2008). Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc Natl Acad Sci USA 105: 13532-13537.
73. Han X., Lin X., Seliger AR, Eastcott J., Kawai T., Taubman MA (2009). Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria. Oral Microbiol Immunol 24: 190-196.
74. Hannas AR, Pereira JC, Granjeiro JM, Tjäderhane L. (2007). The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 65: 1-13.
75. Hasturk H., Kantarci A., Ohira T., Arita M., Ebrahimi N., Chiang N., et al. (2006). RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J 20: 401-403.
76. Hasturk H., Kantarci A., Goguet-Surmenian E., Blackwood A., Andry C., Serhan CN, et al. (2007). Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 179: 7021-7029.
77. Herminajeng E., Asmara W., Yuswanto A., Barid I., Sosroseno W. (2001). Protective humoral immunity induced by surface-associated material from Actinobacillus actinomycetemcomitans in mice. Microbes Infect 3: 997-1003.
78. Honda T., Domon H., Okui T., Kajita K., Amanuma R., Yamazaki K. (2006). Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clin Exp Immunol 144: 35-40.
79. Hosokawa Y., Hosokawa I., Ozaki K., Nakae H., Matsuo T. (2009). Cytokines differentially regulate CXCL10 production by interferon-gamma-stimulated or tumor necrosis factor-alpha-stimulated human gingival fibroblasts J Periodontal Res 44: 225-231.
80. Ihn H., Yamane K., Asano Y., Kubo M., Tamaki K. (2002). IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase dependent pathway. J Immunol 168: 1895-1902.
81. James GA, Swogger E., Wolcott R., Pulcini E., Secor P., Sestrich J., et al. (2008). Biofilms in chronic wounds. Wound Repair Regen 16: 37-44.
82. Jankovic D., Liu Z., Gause WC (2001). Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol 22: 450-457.
83. Jarnicki AG, Fallon PG (2003). T helper type-2 cytokine responses: potential therapeutic targets. Curr Opin Pharmacol 3: 449-455.
84. Jenkinson HF, Lamont RJ (2005). Oral microbial communities in sickness and in health. Trends Microbiol 13: 589-595.
85. Ji JD, Park-Min KH, Shen Z., Fajardo RJ, Goldring SR, McHugh KP, et al. (2009). Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J Immunol 183: 7223-7233.
86. Ji S., Hyun J., Park E., Lee BL, Kim KK, Choi Y. (2007). Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J Periodontal Res 42: 410-419.
87. Ji S., Shin JE, Kim YS, Oh JE, Min BM, Choi Y. (2009). Toll-like receptor 2 and NALP2 mediate induction of human beta-defensins by Fusobacterium nucleatum in gingival epithelial cells. Infect Immun 77: 1044-1052.
88. Jin Q., Cirelli JA, Park CH, Sugai JV, Taba M. Jr, Kostenuik PJ, et al. (2007). RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol 78: 1300-1308.
89. Johnson RB, Serio FG (2005). Interleukin-18 concentrations and the pathogenesis of periodontal disease. J Periodontol 76: 785-790.
90. Jorgensen GH, Arnlaugsson S., Theodors A., Ludviksson BR (2010). Immunoglobulin A deficiency and oral health status: a case-control study. J Clin Periodontol 37: 1-8.
91. Jovanovic DV, Di Battista JA, Martel-Pelletier J., Jolicoeur FC, He Y., Zhang M., et al. (1998). IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 160: 3513-3521.
92. Kalinski P., Moser M. (2005). Consensual immunity: success-driven development of T-helper-1 and T-helper-2 responses. Nat Rev Immunol 5: 251-260.
93. Kantarci A., Hasturk H., Van Dyke TE (2006). Host-mediated resolution of inflammation in periodontal diseases. Periodontol 2000 40: 144-163.
94. Katoh M., Saito S., Takiguchi H., Abiko Y. (2000). Bactericidal activity of a monoclonal antibody against a recombinant 40-kDa outer membrane protein of Porphyromonas gingivalis. J Periodontol 71: 368-375.
95. Kawai T., Eisen-Lev R., Seki M., Eastcott JW, Wilson ME, Taubman MA (2000). Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 164: 2102-2109.
96. Kawai T., Matsuyama T., Hosokawa Y., Makihira S., Seki M., Karimbux NY, et al. (2006). B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 169: 987-998.
97. Kelchtermans H., Schurgers E., Geboes L., Mitera T., Van Damme J., Van Snick J., et al. (2009). Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. Arthritis Res Ther 11: R122.
98. Kikkert R., Laine ML, Aarden LA, van Winkelhoff AJ (2007). Activation of Toll-like receptors 2 and 4 by Gram-negative periodontal bacteria. Oral Microbiol Immunol 22: 145-151.
99. Kim H., Choi HK, Shin JH, Kim KH, Huh JY, Lee SA, et al. (2009). Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J Clin Invest 119: 813-825.
100. Kindle L., Rothe L., Kriss M., Osdoby P., Collin-Osdoby P. (2006). Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts. J Bone Miner Res 21: 193-206.
101. Kopitar AN, Ihan Hren N., Ihan A. (2006). Commensal oral bacteria antigens prime human dendritic cells to induce Th1, Th2 or Treg differentiation. Oral Microbiol Immunol 21: 1-5.
102. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., et al. (1999). IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103: 1345-1352.
103. Koutouzis T., Haber D., Shaddox L., Aukhil I., Wallet SM (2009). Autoreactivity of serum immunoglobulin to periodontal tissue components: a pilot study. J Periodontol 80: 625-633.
104. Krauss JL, Potempa J., Lambris JD, Hajishengallis G. (2010). Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host. Periodontol 2000 52: 141-162.
105. Kumada M., Kihara S., Ouchi N., Kobayashi H., Okamoto Y., Ohashi K., et al. (2004). Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 109: 2046-2049.
106. Kwan Tat S., Padrines M., Theoleyre S., Heymann D., Fortun Y. (2004). IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15: 49-60.
107. Lacey DC, Simmons PJ, Graves SE, Hamilton JA (2009). Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis Cartilage 17: 735-742.
108. Lappin DF, MacLeod CP, Kerr A., Mitchell T., Kinane DF (2001). Anti-inflammatory cytokine IL-10 and T cell cytokine profile in periodontitis granulation tissue. Clin Exp Immunol 123: 294-300.
109. Leibbrandt A., Penninger JM (2008). RANK/RANKL: regulators of immune responses and bone physiology. Ann NY Acad Sci 1143: 123-150.
110. Lemos HP, Grespan R., Vieira SM, Cunha TM, Verri WA Jr, Fernandes KS, et al. (2009). Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc Natl Acad Sci USA 106: 5954-5959.
111. Liang S., Hosur KB, Domon H., Hajishengallis G. (2010). Periodontal inflammation and bone loss in aged mice. J Periodontal Res [Epub ahead of print March 9, 2010 ] (in press).
112. Lima HR, Gelani V., Fernandes AP, Gasparoto TH, Torres SA, Santos CF, et al. (2010). The essential role of Toll like receptor-4 in the control of Aggregatibacter actinomycetemcomitans infection in mice. J Clin Periodontol 37: 248-254.
113. Liu D., Yao S., Wise GE (2006). Effect of interleukin-10 on gene expression of osteoclastogenic regulatory molecules in the rat dental follicle. Eur J Oral Sci 114: 42-49.
114. Liu YC, Lerner UH, Teng YT (2010). Cytokine responses against periodontal infection: protective and destructive roles. Periodontol 2000 52: 163-206.
115. Mahanonda R., Pichyangkul S. (2007). Toll-like receptors and their role in periodontal health and disease. Periodontol 2000 43: 41-55.
116. Malemud CJ (2006). Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11: 1696-1701.
117. Martinelli S., Urosevic M., Daryadel A., Oberholzer PA, Baumann C., Fey MF, et al. (2004). Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J Biol Chem 279: 44123-44132.
118. Mayer Y., Balbir-Gurman A., Machtei EE (2009). Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis. J Periodontol 80: 1414-1420.
119. Menezes R., Garlet TP, Letra A., Bramante CM, Campanelli AP, Figueira Rde C., et al. (2008). Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions. J Endod 34: 932-938.
120. Miyasaki KT, Wilson ME, Brunetti AJ, Genco RJ (1986). Oxidative and nonoxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils. Infect Immun 53: 154-160.
121. Momoi F., Hashizume T., Kurita-Ochiai T., Yuki Y., Kiyono H., Yamamoto M. (2008). Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies. Infect Immun 76: 2777-2784.
122. Murphy KM, Reiner SL (2002). The lineage decisions of helper T cells. Nat Rev Immunol 2: 933-944.
123. Musacchio E., Valvason C., Botsios C., Ostuni F., Furlan A., Ramonda R., et al. (2009). The tumor necrosis factor-{alpha}-blocking agent infliximab inhibits interleukin 1beta (IL-1beta) and IL-6 gene expression in human osteoblastic cells. J Rheumatol 36: 1575-1579.
124. Nakajima T., Ueki-Maruyama K., Oda T., Ohsawa Y., Ito H., Seymour GJ, et al. (2005). Regulatory T-cells infiltrate periodontal disease tissues. J Dent Res 84: 639-643.
125. Nakamura H., Fukusaki Y., Yoshimura A., Shiraishi C., Kishimoto M., Kaneko T., et al. (2008). Lack of Toll-like receptor 4 decreases lipopolysaccharide-induced bone resorption in C3H/HeJ mice in vivo. Oral Microbiol Immunol 23: 190-195.
126. Naundorf S., Schroder M., Hoflich C., Suman N., Volk HD, Grutz G (2009). IL-10 interferes directly with TCR-induced IFN-gamma but not IL-17 production in memory T cells. Eur J Immunol 39: 1066-1077.
127. Nibali L., Ready DR, Parkar M., Brett PM, Wilson M., Tonetti MS, et al. (2007). Gene polymorphisms and the prevalence of key periodontal pathogens. J Dent Res 86: 416-420.
128. Nibali L., Tonetti MS, Ready D., Parkar M., Brett PM, Donos N., et al. (2008). Interleukin-6 polymorphisms are associated with pathogenic bacteria in subjects with periodontitis. J Periodontol 79: 677-683.
129. Noguchi K., Ishikawa I. (2007). The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontol 2000 43: 85-101.
130. Nussbaum G., Ben-Adi S., Genzler T., Sela M., Rosen G. (2009). Involvement of Toll-like receptors 2 and 4 in the innate immune response to Treponema denticola and its outer sheath components. Infect Immun 77: 3939-3947.
131. Ohyama H., Kato-Kogoe N., Kuhara A., Nishimura F., Nakasho K., Yamanegi K., et al. (2009). The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res 88: 633-638.
132. Okada H., Murakami S. (1998). Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 9: 248-266.
133. Okada N., Kobayashi M., Mugikura K., Okamatsu Y., Hanazawa S., Kitano S., et al. (1997). Interleukin-6 production in human fibroblasts derived from periodontal tissues is differentially regulated by cytokines and a glucocorticoid. J Periodontal Res 32: 559-569.
134. Okugawa T., Kaneko T., Yoshimura A., Silverman N., Hara Y. (2010). NOD1 and NOD2 mediate sensing of periodontal pathogens. J Dent Res 89: 186-191.
135. Oliveira SH, Canetti C., Ribeiro RA, Cunha FQ (2008). Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells. Inflammation 31: 36-46.
136. Orima K., Yamazaki K., Aoyagi T., Hara K. (1999). Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue. Clin Exp Immunol 115: 153-160.
137. Oseko F., Yamamoto T., Akamatsu Y., Kanamura N., Iwakura Y., Imanishi J., et al. (2009). IL-17 is involved in bone resorption in mouse periapical lesions. Microbiol Immunol 53: 287-294.
138. Ouhara K., Komatsuzawa H., Yamada S., Shiba H., Fujiwara T., Ohara M., et al. (2005). Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother 55: 888-896.
139. Page RC, Lantz MS, Darveau R., Jeffcoat M., Mancl L., Houston L., et al. (2007). Immunization of Macaca fascicularis against experimental periodontitis using a vaccine containing cysteine proteases purified from Porphyromonas gingivalis. Oral Microbiol Immunol 22: 162-168.
140. Parfitt AM (1982). The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. Metab Bone Dis Relat Res 4: 1-6.
141. Park-Min KH, Ji JD, Antoniv T., Reid AC, Silver RB, Humphrey MB, et al. (2009). IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J Immunol 183: 2444-2455.
142. Pasquali P., Thornton AM, Vendetti S., Pistoia C., Petrucci P., Tarantino M., et al. (2010). CD4+CD25+ T regulatory cells limit effector T cells and favor the progression of brucellosis in BALB/c mice. Microbes Infect 12: 3-10.
143. Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C., Willis CR, et al. (1998). TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 160: 943-952.
144. Pestka S., Krause CD, Sarkar D., Walter MR, Shi Y., Fisher PB (2004). Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979.
145. Pfeffer K., Matsuyama T., Kundig TM, Wakeham A., Kishihara K., Shahinian A., et al. (1993). Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467.
146. Pouliot M., Serhan CN (1999). Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases. J Periodontal Res 34: 370-373.
147. Pouliot M., Clish CB, Petasis NA, Van Dyke TE, Serhan CN (2000). Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 39: 4761-4768.
148. Pradeep AR, Roopa Y., Swati PP (2008). Interleukin-4, a T-helper 2 cell cytokine, is associated with the remission of periodontal disease. J Periodontal Res 43: 712-716.
149. Preshaw PM (2008). Host response modulation in periodontics. Periodontol 2000 48: 92-110.
150. Puklo M., Guentsch A., Hiemstra PS, Eick S., Potempa J. (2008). Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol 23: 328-335.
151. Ramamurthy NS, Greenwald RA, Celiker MY, Shi EY (2005). Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases. J Periodontol 76: 229-233.
152. Rams TE, Listgarten MA, Slots J. (2006). Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence. J Periodontal Res 41: 228-234.
153. Repeke CE, Ferreira SB Jr, Claudino M., Silveira EM, de Assis GF, Avila-Campos MJ, et al. (2010). Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. Bone 46: 1122-1130.
154. Rushbrook SM, Ward SM, Unitt E., Vowler SL, Lucas M., Klenerman P., et al. (2005). Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 79: 7852-7859.
155. Saidenberg-Kermanac'h N., Bessis N., Lemeiter D., de Vernejoul MC, Boissier MC, Cohen-Solal M. (2004). Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis. J Clin Immunol 24: 370-378.
156. Saito S., Hayakawa M., Hiratsuka K., Takiguchi H., Abiko Y. (1996). Complement-mediated killing of Porphyromonas gingivalis 381 by the immunoglobulin G induced by recombinant 40-kDa outer membrane protein. Biochem Mol Med 58: 184-191.
157. Sallusto F., Lanzavecchia A. (2009). Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur J Immunol 39: 2076-2082.
158. Sartori R., Li F., Kirkwood KL (2009). MAP kinase phosphatase-1 protects against inflammatory bone loss. J Dent Res 88: 1125-1130.
159. Sasaki H., Okamatsu Y., Kawai T., Kent R., Taubman M., Stashenko P. (2004). The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J Periodontal Res 39: 432-441.
160. Sasaki H., Suzuki N., Kent R. Jr, Kawashima N., Takeda J., Stashenko P. (2008). T cell response mediated by myeloid cell-derived IL-12 is responsible for Porphyromonas gingivalis-induced periodontitis in IL-10-deficient mice. J Immunol 180: 6193-6198.
161. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., et al. (2006). Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203: 2673-2682.
162. Schenkein HA (1991). The role of complement in periodontal diseases. Crit Rev Oral Biol Med 2: 65-81.
163. Schroder K., Hertzog PJ, Ravasi T., Hume DA (2004). Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189.
164. Serhan CN, Chiang N., Van Dyke TE (2008). Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361.
165. Shaddox L., Wiedey J., Bimstein E., Magnuson I., Clare-Salzler M., Aukhil I., et al. (2010). Hyper-responsive phenotype in localized aggressive periodontitis. J Dent Res 89: 143-148.
166. Shao H., Demuth DR (2010). Quorum sensing regulation of biofilm growth and gene expression by oral bacteria and periodontal pathogens. Periodontol 2000 52: 53-67.
167. Shelburne CE, Shelburne PS, Dhople VM, Sweier DG, Giannobile WV, Kinney JS, et al. (2008). Serum antibodies to Porphyromonas gingivalis chaperone HtpG predict health in periodontitis susceptible patients. PLoS One 3: e1984.
168. Shevach EM (2009). Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
169. Shin JE, Kim YS, Oh JE, Min BM, Choi Y. (2010). Treponema denticola suppresses expression of human {beta}-defensin-3 in gingival epithelial cells through inhibition of the Toll-like receptor 2 axis Infect Immun 78: 672-679.
170. Silva MT (2010). Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens. J Leukoc Biol 87: 805-813.
171. Stashenko P., Gonçalves RB, Lipkin B., Ficarelli A., Sasaki H., Campos-Neto A. (2007). Th1 immune response promotes severe bone resorption caused by Porphyromonas gingivalis. Am J Pathol 170: 203-213.
172. Steinsvoll S., Halstensen TS, Schenck K. (1999). Extensive expression of TGF-beta1 in chronically-inflamed periodontal tissue. J Clin Periodontol 26: 366-373.
173. Takahashi K., Azuma T., Motohira H., Kinane DF, Kitetsu S. (2005). The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol 32: 369-374.
174. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., et al. (2000). T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408: 600-605.
175. Takayanagi H., Sato K., Takaoka A., Taniguchi T. (2005). Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 208: 181-193.
176. Taubman MA, Han X., Larosa KB, Socransky SS, Smith DJ (2007). Periodontal bacterial DNA suppresses the immune response to mutans streptococcal glucosyltransferase. Infect Immun 75: 4088-4096.
177. Teng YT, Mahamed D., Singh B. (2005). Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo. Infect Immun 73: 3453-3461.
178. Thunell DH, Tymkiw KD, Johnson GK, Joly S., Burnell KK, Cavanaugh JE, et al. (2009). A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. J Periodontal Res 45: 148-152.
179. Tomomatsu N., Aoki K., Alles N., Soysa NS, Hussain A., Nakachi H., et al. (2009). LPS-induced inhibition of osteogenesis is TNF-alpha dependent in a murine tooth extraction model. J Bone Miner Res 24: 1770-1781.
180. Tonetti MS, Claffey N. (2005). Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. Group C consensus report of the 5th European Workshop in Periodontology. J Clin Periodontol 32 (Suppl 6). 210-213.
181. Tribble GD, Lamont RJ (2010). Bacterial invasion of epithelial cells and spreading in periodontal tissue. Periodontol 2000 52: 68-83.
182. Trombone AP, Cardoso CR, Repeke CE, Ferreira SB Jr, Martins W. Jr, Campanelli AP, et al. (2008). Tumor necrosis factor-alpha -308G/A single nucleotide polymorphism and red-complex periodontopathogens are independently associated with increased levels of tumor necrosis factor-alpha in diseased periodontal tissues. J Periodontal Res 44: 598-608.
183. Trombone AP, Ferreira SB Jr, Raimundo FM, de Moura KC, Avila-Campos MJ, Silva JS, et al. (2009). Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection. J Periodontal Res 44: 443-451.
184. Uehara A., Takada H. (2007). Functional TLRs and NODs in human gingival fibroblasts. J Dent Res 86: 249-254.
185. Uehara A., Takada H. (2008). Synergism between TLRs and NOD1/2 in oral epithelial cells. J Dent Res 87: 682-686.
186. Ukai T., Yumoto H., Gibson FC 3rd, Genco CA (2008). Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production. Infect Immun 76: 812-819.
187. Van Dyke TE (2009). The etiology and pathogenesis of periodontitis revisited. J Appl Oral Sci 17 (1). pii.S1678-77572009000100001.
188. Venketaraman V., Lin AK, Le A., Kachlany SC, Connell ND, Kaplan JB (2008). Both leukotoxin and poly-N-acetylglucosamine surface polysaccharide protect Aggregatibacter actinomycetemcomitans cells from macrophage killing. Microb Pathog 45: 173-180.
189. Vernal R., Dutzan N., Chaparro A., Puente J., Valenzuela MA, Gamonal J. (2005). Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 32: 383-389.
190. Verstappen J., Von den Hoff JW (2006). Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease. J Dent Res 85: 1074-1084.
191. Vitkov L., Klappacher M., Hannig M., Krautgartner WD (2009). Extracellular neutrophil traps in periodontitis. J Periodontal Res 44: 664-672.
192. Vitkov L., Klappacher M., Hannig M., Krautgartner WD (2010). Neutrophil fate in gingival crevicular fluid. Ultrastruct Pathol 34: 25-30.
193. Wajant H., Pfizenmaier K., Scheurich P. (2003). Tumor necrosis factor signaling. Cell Death Differ 10: 45-65.
194. Wakabayashi H., Yamauchi K., Kobayashi T., Yaeshima T., Iwatsuki K., Yoshie H. (2009). Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob Agents Chemother 53: 3308-3316.
195. Wang M., Hajishengallis G. (2008). Lipid raft-dependent uptake, signalling and intracellular fate of Porphyromonas gingivalis in mouse macrophages. Cell Microbiol 10: 2029-2042.
196. Wang M., Krauss JL, Domon H., Hosur KB, Liang S., Magotti P., et al. (2010). Microbial hijacking of complement-Toll-like receptor crosstalk. Sci Signal 3 :ra11.
197. Weaver CT, Hatton RD (2009). Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol 9: 883-889.
198. Wilensky A., Polak D., Awawdi S., Halabi A., Shapira L., Houri-Haddad Y. (2009). Strain-dependent activation of the mouse immune response is correlated with Porphyromonas gingivalis-induced experimental periodontitis. J Clin Periodontol 36: 915-921.
199. Xynogala I., Volgina A., DiRienzo JM, Korostoff J (2009). Evaluation of the humoral immune response to the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans Y4 in subjects with localized aggressive periodontitis. Oral Microbiol Immunol 24: 116-123.
200. Yago T., Nanke Y., Ichikawa N., Kobashigawa T., Mogi M., Kamatani N., et al. (2009). IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17. J Cell Biochem 108: 947-955.
201. Yamaguchi M., Ukai T., Kaneko T., Yoshinaga M., Yokoyama M., Ozaki Y., et al. (2008). T cells are able to promote lipopolysaccharide-induced bone resorption in mice in the absence of B cells. J Periodontal Res 43: 549-555.
202. Yoshimura A., Mori H., Ohishi M., Aki D., Hanada T. (2003). Negative regulation of cytokine signaling influences inflammation. Curr Opin Immunol 15: 704-708.
203. Yoshimura A., Naka T., Kubo M. (2007). SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7: 454-465.
204. Yu F., Xu QA, Sun G., Chen W. (2009). CTLA4 targeting strategy in DNA vaccination against periodontitis. Med Hypotheses 72: 41-42.
205. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C., Baker PJ, Smith JB, et al. (2007). An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109: 3794-3802.
206. Zhang T., Hashizume T., Kurita-Ochiai T., Yamamoto M. (2009). Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity. Biochem Biophys Res Commun 390: 937-941.
207. Zhang X., Teng YT (2006). Interleukin-10 inhibits Gram-negative-microbe- specific human receptor activator of NF-kappaB ligand-positive CD4+-Th1-cell-associated alveolar bone loss in vivo. Infect Immun 74: 4927-4931.
208. Zwerina J., Hayer S., Tohidast-Akrad M., Bergmeister H., Redlich K., Feige U., et al. (2004). Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum 50: 277-290.
209. Zwerina J., Redlich K., Polzer K., Joosten L., Kronke G., Distler J., et al. (2007). TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA 104: 11742-11747.